Drugs / ArtemiC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04382040 | May → Nov 2020 | COVID-19 | MGC Pharmaceuticals d.o.o | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ArtemiC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04382040 ↗ |
| Route | Oral | “Evaluation of the effect of oral administration of the study drug will be assessed by determining the clinical and laboratory tests as summarized below” NCT04382040 ↗ |